WGU D116 ADVANCED PHARMACOLOGY OBJECTIVE ASSESSMENT EXAM 2026 | VERIFIED QUESTIONS & CORRECT SOLUTIONS

WGU D116 ADVANCED PHARMACOLOGY
OBJECTIVE ASSESSMENT EXAM 2026 |
VERIFIED QUESTIONS & CORRECT SOLUTIONS

WGU D116 — ADVANCED PHARMACOLOGY

OBJECTIVE ASSESSMENT EXAM 2026 | VERIFIED QUESTIONS & CORRECT
SOLUTIONS

Multiple Choice Questions



OVERVIEW & HOW TO USE THIS MATERIAL

This resource is designed to help you master the core competencies tested in the WGU
D116 Advanced Pharmacology Objective Assessment. It covers a wide range of
pharmacological principles at an advanced level, including drug mechanisms,
therapeutic applications, adverse effects, drug interactions, and clinical decision-making
across body systems.
How to study effectively with this material:

Work through the questions one at a time without looking at the answer first — treat
each question as a real exam scenario. After selecting your answer mentally, reveal the
CORRECT ANSWER and read the RATIONALE carefully. The RATIONALE is the
most important part: it teaches you why the answer is correct, which is far more
valuable than memorizing answers. Group your review by topic after your first pass so
you can strengthen weak areas. Return to questions you got wrong at least twice before
your assessment date. This material is best used alongside your WGU course
materials, not as a replacement.



EXAM FORMAT GUIDE

• Each question has 5 options: A through E

• The CORRECT ANSWER appears immediately after the options

• The RATIONALE appears directly below the CORRECT ANSWER

• A divider line separates each question

,Question 1. A nurse practitioner is reviewing the concept of drug bioavailability. Which
of the following best defines bioavailability?

A. The speed at which a drug reaches peak plasma concentration

B. The fraction of an administered drug that reaches systemic circulation in unchanged
form

C. The volume of plasma cleared of a drug per unit time

D. The degree to which a drug binds to plasma proteins

E. The rate at which a drug is metabolized by the liver

CORRECT ANSWER: B. The fraction of an administered drug that reaches
systemic circulation in unchanged form

RATIONALE: Bioavailability refers to the proportion of a drug that enters systemic
circulation and is available to produce a pharmacological effect. Intravenous
administration gives 100% bioavailability; oral drugs undergo first-pass metabolism
which reduces bioavailability.



Question 2. Which pharmacokinetic parameter describes the time required for the
plasma concentration of a drug to decrease by half?

A. Volume of distribution

B. Clearance

C. Area under the curve (AUC)

D. Half-life (t½)
E. Bioavailability

CORRECT ANSWER: D. Half-life (t½)

RATIONALE: Half-life is the time it takes for the concentration of a drug in plasma
to reduce by 50%. It determines dosing intervals and time to steady state
(approximately 4–5 half-lives).


Question 3. A patient is prescribed a drug with zero-order kinetics. Which statement
best describes this type of elimination?
A. A constant fraction of the drug is eliminated per unit time

,B. Elimination rate increases as plasma concentration increases

C. A constant amount of the drug is eliminated per unit time regardless of concentration

D. The drug is eliminated faster when protein binding increases

E. Half-life shortens as the dose increases

CORRECT ANSWER: C. A constant amount of the drug is eliminated per unit
time regardless of concentration

RATIONALE: Zero-order kinetics (also called saturation kinetics) occurs when
elimination mechanisms are saturated. The same absolute amount is eliminated per unit
time regardless of plasma concentration. Ethanol and phenytoin at toxic doses are
classic examples.



Question 4. Which of the following best describes the volume of distribution (Vd)?

A. The actual physical volume of blood in the body

B. The ratio of drug concentration in plasma to urine
C. A hypothetical volume that relates the total amount of drug in the body to its plasma
concentration

D. The total volume of fluid cleared of drug per hour
E. The volume of drug needed to reach therapeutic effect

CORRECT ANSWER: C. A hypothetical volume that relates the total amount of
drug in the body to its plasma concentration

RATIONALE: Vd = Amount of drug in body ÷ Plasma concentration. A large Vd
indicates extensive tissue distribution (e.g., lipophilic drugs), while a small Vd suggests
the drug stays mainly in plasma.


Question 5. A drug that acts as a full agonist differs from a partial agonist in that a full
agonist:
A. Binds irreversibly to the receptor

B. Produces a maximal response when it occupies the receptor
C. Requires a lower dose to produce any effect

, D. Blocks the receptor without producing a response

E. Competes with endogenous ligands for binding sites only

CORRECT ANSWER: B. Produces a maximal response when it occupies the
receptor

RATIONALE: Full agonists have high intrinsic efficacy and can produce the
maximum possible response. Partial agonists bind the receptor but produce a
submaximal response even at full receptor occupancy due to lower intrinsic efficacy.



Question 6. Which cytochrome P450 enzyme is most responsible for the metabolism of
the majority of clinically used drugs?

A. CYP1A2

B. CYP2C9

C. CYP2D6

D. CYP3A4
E. CYP2E1

CORRECT ANSWER: D. CYP3A4

RATIONALE: CYP3A4 is the most abundant hepatic CYP enzyme and is
responsible for metabolizing approximately 50% of all clinically used drugs. It is also
highly expressed in the intestinal wall, contributing to first-pass metabolism.


Question 7. Competitive antagonism is best characterized by which of the following?

A. Permanent binding to the receptor that cannot be overcome

B. Reduction of maximum drug effect regardless of agonist concentration

C. Rightward shift of the dose-response curve with no change in maximum effect

D. Binding to an allosteric site, changing receptor conformation

E. Decreased receptor number over time

CORRECT ANSWER: C. Rightward shift of the dose-response curve with no
change in maximum effect